FMP
NASDAQ
1.66 USD
0.02 (1.2%)
Dr. Mark Strobeck Ph.D.
Healthcare
Drug Manufacturers - Specialty & Generic
https://www.rockwellmed.com
NASDAQ
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte...
0001041024
US7743743004
774374300
30142 South Wixom road
248 960 9009
US
237
Jan 27, 1998
0001041024
NASDAQ
Drug Manufacturers -...
Healthcare
774374300
US7743743004
US
1.66
1.16
230.12k
48.7M
-
1.16-6.24
-0.02
-
-
-
-
-4.49
-
https://www.rockwellmed.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.